The Lao Bear version of Anagrelide is an oral antiproliferative drug for essential thrombocythemia, which precisely reduces platelet count by inhibiti···【Read More】
Update: 2026-06-05Source: Haiou HealthViews: 130
In the treatment landscape for elevated platelet counts caused by myeloproliferative neoplasms, the Laos Daxiong version of Anagrelide,凭借规范的仿制工艺与与原研药等···【Read More】
Update: 2026-06-05Source: Haiou HealthViews: 132
The Ibrutinib (ILUDX) produced by Laos Big Bear Pharmaceuticals is a high-quality oral BTK inhibitor generic drug. While retaining the same core ingre···【Read More】
Update: 2026-06-05Source: Haiou HealthViews: 166
While the insured price of the imported original drug Ibrutinib can still be several thousand yuan per box, the Lao Big Bear Pharmaceutical version ha···【Read More】
Update: 2026-06-05Source: Haiou HealthViews: 124
The Lao Bear Pharmaceuticals version of Ibrutinib, brand name ILUDX, is an oral BTK inhibitor used to treat various B-cell malignancies, offering a mo···【Read More】
Update: 2026-06-05Source: Haiou HealthViews: 147
The appearance of the Lao Dabear version of Mobocertinib has not only broken the monopoly of high-priced original drugs but has also become a highly a···【Read More】
Update: 2026-06-04Source: Haiou HealthViews: 121
As the first Southeast Asian generic option for the originator drug Mobocertinib, the Laos Dabear version of Mobocertinib brings new hope to patients ···【Read More】
Update: 2026-06-04Source: Haiou HealthViews: 123
The Lao Daewoong version of Mobocertinib is an oral targeted drug for non-small cell lung cancer with EGFR exon 20 insertion mutation. It is a high-qu···【Read More】
Update: 2026-06-04Source: Haiou HealthViews: 117
In the global pharmaceutical landscape where innovative drugs and generics coexist, the Lao Big Bear version of Acalabrutinib, with its strict quality···【Read More】
Update: 2026-06-04Source: Haiou HealthViews: 123
As an important generic version of the Bruton's tyrosine kinase (BTK) inhibitor, the Laos Dabear version of Acalabrutinib is helping more patients···【Read More】
Update: 2026-06-04Source: Haiou HealthViews: 137
The acalabrutinib generic version launched by Lao Bear Pharmaceutical provides cancer patients worldwide with a new cost-effective treatment option be···【Read More】
Update: 2026-06-04Source: Haiou HealthViews: 116
For patients who require long-term use of Upadacitinib to control conditions such as rheumatoid arthritis and atopic dermatitis, the generic version l···【Read More】
Update: 2026-06-03Source: Haiou HealthViews: 151
In the field of autoimmune disease drugs, the Dabear version of Upadacitinib from Laos is gradually becoming a new hope for patients in low- and middl···【Read More】
Update: 2026-06-03Source: Haiou HealthViews: 134
Upadacitinib produced by Lao Big Bear Pharmaceutical Company, as a legal generic version of the originator upadacitinib, provides a more cost-controll···【Read More】
Update: 2026-06-03Source: Haiou HealthViews: 138
Against the backdrop of increasing challenges in access to innovative drugs, the Laos Dabear version of Sotorasib, with its active ingredients highly ···【Read More】
Update: 2026-06-03Source: Haiou HealthViews: 133
Copyright2024@ BIGBEAR All right reserved Bigbear | Bigbear Pharmaceutical | Bigbear Laos